Xbrane Biopharma AB (publ) (STO:XBRANE)
10.95
-0.55 (-4.78%)
Nov 19, 2026, 9:35 AM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 225.63 million as of November 18, 2026. It is the 35,289th most valuable company in the world and the 474th biggest in Sweden. Its market cap has increased by 9.99% in one year.
Market Cap
225.63M
Enterprise Value
252.15M
Revenue
127.95M
Global Rank
Country Rank
#474 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 225.63M, an increase of 72.17%. That is a compound annual growth rate of 5.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 225.63M | 7.35% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 386.26M |
| Corline Biomedical AB | 376.32M |
| Isofol Medical AB | 339.08M |
| Mendus AB | 256.14M |
| Intervacc AB | 248.79M |
| Initiator Pharma | 184.14M |
| BioInvent International AB | 180.96M |
| Elicera Therapeutics AB | 166.84M |